Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label memantine study in institutionalized patients with Alzheimer's disease
2006-000860-10Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of memantine in Alzheimer's disease (AD), sponsored by Lundbeck. Primary endpoints: Alzheimer's Disease Cooperative Study – Clinical Global Impression of Change, Ferm's modified D-test and 4 more. Started Jun 2006; status: terminated.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2006-000860-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000860-10.